Last reviewed · How we verify

NCT04899388

Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block

Completed Phase 2 Last updated 26 June 2023
What this trial tests

Phase 2 trial testing Pericapsular Nerve Block in Pericapsular Nerve Group Block (PENG Block) in 69 participants. Completed in 20 February 2022.

Timeline
1 June 2021
Primary endpoint
30 December 2021
20 February 2022

Quick facts

Lead sponsorZagazig University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment69
Start date1 June 2021
Primary completion30 December 2021
Estimated completion20 February 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 65 to 75, any sex, with Pericapsular Nerve Group Block (PENG Block) or Lumbar Erector Spinae Plane Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

assess and compare the efficacy of pericapsular nerve group block wersus lumber erector spinae plane block in reducing postoperative pain within the first 24 hours after hip surgeries.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Analgesic Effects of Preemptive Ultrasound-Guided Pericapsular Nerve Group Block in Comparison with Erector Spinae Plane Block in Elderly Undergoing Hip Arthroplasty: A Randomized Controlled Trial.
    Medhat MM, Kamel AAF, Salem DAE, Alagamy SA, et al · · 2023 · cited 5× · PMID 38028113 · DOI 10.5812/aapm-138623

Verify or expand the search:

Other trials of Pericapsular Nerve Block

Trials testing the same drug.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04899388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing